Bloomberg AbbVie Inc. agreed to buy rival drugmaker Allergan Plc for $63 billion in a deal combining the makers of arthritis drug Humira and wrinkle treatment Botox in a bid to kindle growth. The takeover, at a value of $188.24 a share, is a 45 percent premium to Allergan’s closing price. Allergan rose 33 percent to $172 in pre-market trading ...

Bloomberg Capgemini SE said it will acquire Altran Technologies SA in a 3.6 billion-euro ($4.1 billion) deal in order to win more tech clients and keep up with rivals. Paris-based Capgemini is looking to maintain its position as a major IT consultancy in a consolidating industry, as competitors such as Accenture have been building out their sales from digital projects. ...

Bloomberg Apple Inc. is significantly increasing its footprint in Seattle as it expands on a previously announced plan to boost hiring, bringing an additional 2,000 jobs to the area in the next five years. The iPhone maker signed a lease for office space at 333 Dexter, a 660,000-square-foot (61,300-square-meter) development in the South Lake Union neighborhood being built by Kilroy ...